Login
Toggle navigation
Videos
Categories
Trending
Li-Cycle CEO emphasizes top priority with scaled-back Rochester Hub and outlines a three-point plan.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Ajay Kochhar is the President, CEO and co-founder of Li-Cycle.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:00:00
Steppe Gold Discusses Their Approach to Exploration and Production | Bataa Tumur-Ochir , President And Ceo, Steppe Gold Ltd
00:10:00
specialists that partner with founders at the earliest stages to turn great ideas|Pejman Nozad,Founding Managing Partner,Pear VC
00:10:00
Fabricio Mitre Discusses the MITRE Group’s Agricultural Legacy and Growth | Fabrício Mitre, CEO , Mitre Realty Empreendimentos e Participações SA.
00:10:00
Navigating Private Capital Markets: Insights from Jean Phillippe Keravec at IPEM 2020
00:10:00
Gula Tech Adventures are cyber security industry veterans helping the next generation|Ron Gula,President,Gula Tech Adventures
00:10:00
Patricia Vincent-Collawn, Chair of the Edison Electric Institute and CEO of PNM Resources, provides insights on the U.S. electric and energy landscape.
00:10:00
Thirty Gold Mines: Bill's Insights from One-to-One Mining Investment Conference
00:10:00
Facing Economic Challenges: Germany's Resilience and Adaptation | Manfred Knof , CEO , Commerzbank.
00:10:00
Where Do Millionaires Invest? Insights from ASK Wealth Advisors | Rajesh Saluja, CEO & MD at ASK Wealth Advisors
00:10:00
From Humble Beginnings to a Market Leader - Interview Part 1 | Mr. Keoh Beng Huat, CEO, SFP Tech Holdings Berhad.
00:10:00
Asante Gold's Transformation: From Acquisition to Gold Production at Bibiani Mine
00:10:00
Mid-Year Financial Check-In: Aligning with Your Mission Statement Using the Integrity Report